Girish Aakalu

Currently holds a position at Genocea Biosciences Inc

Position	Company	Period
Chief Business Officer	Genocea Biosciences Inc	Dec. 10, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-04-05	2022-04-04	Genocea Biosciences Inc (GNCA)	S Sale	89,601 +49.6% 338.32 US$4,722,491	89,601 +49.6%	338.32	US$4,722,491
2022-03-17	2022-03-16	Genocea Biosciences Inc (GNCA)	S Sale	30,028 +31.7% 351.45 US$2,416,465	30,028 +31.7%	351.45	US$2,416,465